Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $681.26 | 37 | 93.6% |
| Education | $46.91 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $183.15 | 10 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $111.32 | 7 | $0 (2023) |
| Axsome Therapeutics, Inc. | $109.91 | 5 | $0 (2023) |
| ITI, Inc. | $60.87 | 2 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $49.79 | 3 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.93 | 3 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $38.98 | 2 | $0 (2023) |
| Alkermes, Inc. | $38.64 | 2 | $0 (2023) |
| AngioDynamics, Inc. | $27.38 | 1 | $0 (2021) |
| Ironshore Pharmaceuticals Inc. | $24.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.61 | 1 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($19.61) |
| 2023 | $465.14 | 24 | Axsome Therapeutics, Inc. ($109.91) |
| 2022 | $216.04 | 12 | ABBVIE INC. ($94.24) |
| 2021 | $27.38 | 1 | AngioDynamics, Inc. ($27.38) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 12/14/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: Neuropsychiatry | ||||||
| 12/06/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Central Nervous System | ||||||
| 11/09/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.10 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Neurology | ||||||
| 10/18/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Central Nervous System | ||||||
| 10/06/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.00 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/14/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.56 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/30/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Neuroscience | ||||||
| 08/24/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: Neurology | ||||||
| 08/17/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Neuropsychiatry | ||||||
| 08/03/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Neurology | ||||||
| 06/16/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: PSYCHIATRY | ||||||
| 06/08/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Psychology/Psychiatric | ||||||
| 03/16/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: PSYCHIATRY | ||||||
| 03/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: NEUROSCIENCE | ||||||
| 03/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: NEUROSCIENCE | ||||||
| 02/17/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: CNS | ||||||
| 02/09/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 39 | 115 | $14,055 | $6,929 |
| 2022 | 1 | 18 | 29 | $4,821 | $2,380 |
| 2021 | 3 | 133 | 145 | $29,734 | $12,642 |
| 2020 | 4 | 219 | 282 | $55,293 | $19,317 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 60 | $9,900 | $4,536 | 45.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 20 | 55 | $4,155 | $2,392 | 57.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 29 | $4,821 | $2,380 | 49.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 55 | 55 | $15,565 | $6,065 | 39.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 43 | 51 | $9,333 | $4,318 | 46.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 35 | 39 | $4,836 | $2,259 | 46.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 163 | $30,165 | $10,074 | 33.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 48 | 48 | $13,584 | $4,971 | 36.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 37 | 49 | $6,076 | $2,269 | 37.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 22 | 22 | $5,468 | $2,003 | 36.6% |
About Melissa Fox
Melissa Fox is a Psychiatric/Mental Health healthcare provider based in Tiffin, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2013. The National Provider Identifier (NPI) number assigned to this provider is 1548698327.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Fox has received a total of $728.17 in payments from pharmaceutical and medical device companies, with $19.61 received in 2024. These payments were reported across 38 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($681.26).
As a Medicare-enrolled provider, Fox has provided services to 409 Medicare beneficiaries, totaling 571 services with total Medicare billing of $41,268. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Family
- Location Tiffin, OH
- Active Since 10/14/2013
- Last Updated 12/02/2025
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1548698327
Products in Payments
- VRAYLAR (Drug) $183.15
- CAPLYTA (Drug) $80.48
- Auvelity (Drug) $77.16
- REXULTI (Drug) $54.03
- ABILIFY MAINTENA (Drug) $41.49
- INGREZZA (Drug) $38.98
- Sunosi (Drug) $32.75
- Austedo XR (Drug) $28.10
- TRINTELLIX (Drug) $27.93
- AlphaVac (Device) $27.38
- JORNAY PM (Drug) $24.00
- UZEDY (Drug) $21.69
- ARISTADA (Drug) $21.24
- SPRAVATO (Drug) $20.59
- LYBALVI (Drug) $17.40
- VYVANSE (Drug) $16.00
- ABILIFY ASIMTUFII (Drug) $15.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.